Another bio tech What was I thinking?
"The Company’s cash position of $23.6 million at 31 December 2020 combined with significant accrued research and development rebate credits means Recce Pharmaceuticals is sufficiently funded to execute its development milestones through the 2021 financial year. " interim report 31 dec 2020
"Recce Clinical Pipeline Update " says "Full data" end Q4, 2021 and 2022 and mid-2022 for results add in the wild card Covid data anticipated Q4 2021giving several near term re-ratings.
In for the results pipeline for me . I may need to change my user name to BIOTECH tragicThe little dip today made me jump.
Have a great day all
Another bio tech What was I thinking?"The Company’s cash...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
30.5¢ |
Change
0.005(1.67%) |
Mkt cap ! $87.95M | |||
| Open | High | Low | Value | Volume |
| 31.0¢ | 32.0¢ | 30.5¢ | $20.21K | 64.13K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2925 | 30.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 22727 | 4 |
View Market Depth
| Last trade - 13.38pm 27/06/2025 (20 minute delay) ? |
| RCE (ASX) Chart |